• 989 Citations
  • 16 h-Index
1989 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Paul F. Riska is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Mycobacterium tuberculosis Medicine & Life Sciences
Luciferases Medicine & Life Sciences
Mycobacteriophages Medicine & Life Sciences
Bacteriophages Medicine & Life Sciences
Clostridium difficile Medicine & Life Sciences
Clostridium Infections Medicine & Life Sciences
Mycobacterium Medicine & Life Sciences
Anti-Bacterial Agents Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 1998 2004

Mycobacterium
Tuberculosis
Bacteriophages
Molecular Biology
Mycobacteriophages

Publications 1989 2019

  • 989 Citations
  • 16 h-Index
  • 29 Article
  • 1 Conference contribution
Open Access
Intravenous Immunoglobulins
Human Influenza
Randomized Controlled Trials
Placebos
Infection
9 Citations (Scopus)
Bacteremia
Randomized Controlled Trials
Therapeutics
Anti-Bacterial Agents
Coagulase
1 Citation (Scopus)
Indoleamine-Pyrrole 2,3,-Dioxygenase
Human Influenza
Disease Progression
Tryptophan
Kynurenine
1 Citation (Scopus)

Two for the price of one: Emerging carbapenemases in a returning traveller to New York City

Mittal, J., Szymczak, W. A., Guo, Y., Levi, M. H., Chen, L., Kreiswirth, B. N., Riska, P. F. & Nori, P., Jan 1 2018, In : BMJ Case Reports. 2018, bcr-2018-225440.

Research output: Contribution to journalArticle

Carbapenems
Bangladesh
Enterobacteriaceae Infections
Aztreonam
Klebsiella pneumoniae
41 Citations (Scopus)
Clostridium Infections
Clostridium difficile
Vancomycin
Safety
Therapeutics